Institutional Manager · CIK 0001892770
Knott David M Jr
Syosset, NY · File #028-21815
Latest AUM
$215.9M
Positions
91
Top-10 Concentration
72.4%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| REDUCE | Calumet, Inc. | CLMT | -610,262 | -$12.1M | +$4.6M |
| EXITED | Darling Ingredients Inc. | 237266101 | -300,000 | -$9.3M | $0 |
| EXITED | Avadel Pharmaceuticals plc | G29687103 | -363,000 | -$5.5M | $0 |
| EXITED | Verona Pharma PLC. | 925050106 | -38,355 | -$4.1M | $0 |
| NEW | Cogent Biosciences Inc. | COGT | +102,000 | +$3.6M | $0 |
| REDUCE | Travere Therapeutics, Inc. | TVTX | -74,000 | -$2.8M | +$3.7M |
| EXITED | CSX Corporation | 126408103 | -70,000 | -$2.5M | $0 |
| EXITED | Liquidia Corporation | 53635D202 | -107,783 | -$2.5M | $0 |
| ADD | Alkermes PLC | ALKS | +75,700 | +$2.1M | -$38,986 |
| EXITED | Praxis Precision Medicines, Inc. | 74006W207 | -28,000 | -$1.5M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202591 pos · $215.9M
- 13F HOLDINGS REPORTQ/E Sep 202592 pos · $248.0M
- 13F HOLDINGS REPORTQ/E Jun 202589 pos · $220.6M
- 13F HOLDINGS REPORTQ/E Mar 202588 pos · $212.0M
- 13F HOLDINGS REPORTQ/E Dec 202493 pos · $276.5M
- 13F HOLDINGS REPORTQ/E Sep 202499 pos · $284,570
- 13F HOLDINGS REPORTQ/E Jun 2024106 pos · $250,627
- 13F HOLDINGS REPORTQ/E Mar 2024114 pos · $282,751
- 13F HOLDINGS REPORTQ/E Dec 2023135 pos · $261,929
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Calumet, Inc. | CLMT | 2,214,969 | $44.0M | 20.89% |
| 2 | Apollo Global Management, Inc. | 03769M106 | 225,000 | $32.6M | 15.46% |
| 3 | Alphabet Inc-Cl C | GOOG | 91,200 | $28.6M | 13.58% |
| 4 | Syndax Pharmaceutical, Inc. | SNDX | 415,000 | $8.7M | 4.14% |
| 5 | Xeris Biopharma Holdings, Inc. | XERS | 970,000 | $7.6M | 3.61% |
| 6 | Travere Therapeutics, Inc. | TVTX | 186,000 | $7.1M | 3.37% |
| 7 | Bridgebio Pharma, Inc. | BBIO | 85,000 | $6.5M | 3.09% |
| 8 | Protagonist Therapeutics, Inc | PTGX | 73,000 | $6.4M | 3.03% |
| 9 | JPMorgan Chase & Co. | VYLD | 19,477 | $6.3M | 2.98% |
| 10 | Janus Henderson AAA CLO ETF | 47103U845 | 93,528 | $4.7M | 2.25% |
| 11 | Viridian Therapeutics, Inc. | VRDN | 145,000 | $4.5M | 2.14% |
| 12 | Catalyst Pharmaceuticals, Inc. | CPRX | 189,000 | $4.4M | 2.09% |
| 13 | Cogent Biosciences Inc. | COGT | 102,000 | $3.6M | 1.72% |
| 14 | Arcus Biosciences, Inc. | RCUS | 121,241 | $2.9M | 1.37% |
| 15 | Alkermes PLC | ALKS | 95,000 | $2.7M | 1.26% |
| 16 | DocGo, Inc. | DCGO | 2,670,850 | $2.3M | 1.11% |
| 17 | Cybin Inc | HELP | 285,182 | $2.3M | 1.11% |
| 18 | Cytokinetics, Incorporated | CYTK | 34,000 | $2.2M | 1.03% |
| 19 | AtriCure, Inc. | ATRC | 51,400 | $2.0M | 0.97% |
| 20 | AllianceBernstein Holding L.P. | 01881G106 | 48,000 | $1.8M | 0.88% |